Paradoxical excitation is the uncommon but well-documented phenomenon in which a drug meant to calm you down does the opposite, triggering agitation, restlessness, or outright combativeness instead of sedation. It occurs in fewer than one in a hundred patients receiving benzodiazepines, the drug class where the reaction is best studied, though it also shows up with propofol, antihistamines, and other sedatives.1PubMed. Paradoxical reactions to benzodiazepines: literature review and treatment options The causes trace back to how individual brains handle inhibitory signaling, and some people are far more vulnerable than others.
What It Looks Like in Practice
The hallmark of paradoxical excitation is a behavioral response that directly contradicts the drug’s intended effect. Someone given midazolam before a procedure, for instance, may become inconsolably agitated rather than drowsy. Reported symptoms include increased talkativeness, emotional outbursts, excessive movement, motor restlessness, aggression, disorientation, and even muscle stiffening or jerking.2PubMed Central. Persistent Paradoxical Reaction to Midazolam despite General Anesthesia with Dexmedetomidine In one case involving an 80-year-old woman on alprazolam, clinicians noticed a clear dose-response relationship running in the wrong direction: the higher her dose, the worse her motor agitation, restlessness, and paranoia became. When the dose was reduced, her symptoms eased.3PubMed Central. Paradoxical Reaction to Alprazolam in an Elderly Woman with a History of Anxiety, Mood Disorders, and Hypothyroidism
The reaction typically appears within minutes. In a study of over 2,600 children who received midazolam for endoscopy, the 1.4% who developed paradoxical reactions did so at an average of about 17 minutes after the drug was given, presenting with crying, combativeness, rapid heart rate, and agitation.4PubMed. Paradoxical reactions in children associated with midazolam use during endoscopy This timing is important because it distinguishes the reaction from a delayed complication or an unrelated event. The drug goes in, and the patient promptly does the opposite of what everyone in the room expects.
The Drugs Most Commonly Involved
Benzodiazepines are the textbook example. Midazolam, diazepam, and alprazolam have all been implicated, and paradoxical reactions to this drug class have been reported since chlordiazepoxide was introduced in 1960. The first documented paradoxical reaction to midazolam appeared in the 1980s, not long after the drug was synthesized in 1975.5PubMed Central. Clinical enigma: Case-based systematic review of flumazenil in the management of paradoxical reactions to midazolam – A quarter-century perspective The phenomenon has been consistently reported ever since, though it remains rare enough that many clinicians go years without seeing a case.
Propofol, the intravenous anesthetic widely used for procedural sedation in emergency departments, can produce a similar reaction. Rather than smooth sedation, a patient may become mildly to moderately agitated, sometimes with muscle hypertonicity and jaw clenching (masseter spasm). One emergency department case documented a patient who grew agitated and developed muscle spasms during what should have been a routine orthopedic sedation.6PubMed Central. Paradoxical Agitation and Masseter Spasm During Propofol Procedural Sedation: A Case Report Propofol-related paradoxical excitation can also manifest as seizure-like activity, which complicates the clinical picture further.7Global Journal of Anesthesiology. Seizure-like Activity after Sedation with Propofol
Antihistamines round out the list. Diphenhydramine, the active ingredient in many over-the-counter sleep aids, occasionally produces excitation rather than drowsiness. This reaction has been reported with standard doses in both children and adults, though it is rare enough that relatively few formal case reports exist in the medical literature.8Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. Paradoxic Excitation with Diphenhydramine in an Adult With diphenhydramine, genetic differences in drug metabolism appear to play a role, as discussed below.
Why the Brain Sometimes Responds Backwards
The best-studied explanation centers on the neurotransmitter GABA. Under normal circumstances, GABA is the brain’s primary brake pedal. When benzodiazepines or propofol enhance GABA signaling, they push the nervous system toward calm and sleep. But this neat picture depends on GABA actually being inhibitory in the neurons it reaches, and that is not always guaranteed.
Whether GABA inhibits or excites a neuron depends on the concentration of chloride ions inside the cell. When intracellular chloride levels are low, GABA does its usual job of quieting things down. But in certain conditions, including brain injury, stroke, and immature neural development, intracellular chloride can accumulate to the point where GABA signaling effectively flips its polarity and becomes excitatory. In this scenario, a drug that boosts GABA does not produce sedation. It amplifies excitation.9PubMed Central. Depolarizing GABA and developmental epilepsies Research on benzodiazepine-induced “awakenings” in brain-injured patients has pointed specifically to this chloride shift. Brain trauma and cerebrovascular injury are associated with elevated intracellular chloride, creating conditions where benzodiazepines generate paradoxical reactions rather than sedation.10SpringerOpen / Translational Medicine Communications. Is the awakening produced by benzodiazepines due to excitatory actions of GABA?
A second mechanism involves the concept of disinhibition in cortical circuits. The brain’s inhibitory networks are not a single monolithic system. Some inhibitory neurons primarily suppress other inhibitory neurons. When a sedative drug preferentially damps down one of these inhibitory populations, it can inadvertently release excitatory neurons from their restraints, producing a net increase in brain activity. Computational models of cortical microcircuits show that disruptions to the balance between excitation and inhibition can lead to paradoxical increases in neural firing, even when the initial intervention was supposed to reduce it.11PubMed Central. Paradoxical response reversal of top-down modulation in cortical circuits with three interneuron types For propofol specifically, research suggests the drug’s interaction with GABA-A receptors can switch interneurons from synchronized firing to antisynchronized firing, which may disrupt the orderly inhibition the brain needs to settle down.7Global Journal of Anesthesiology. Seizure-like Activity after Sedation with Propofol
Neither mechanism is mutually exclusive. In a given patient, the chloride polarity shift and the disinhibition pathway may overlap or operate independently. The honest takeaway is that “the drug should make GABA work harder, so the brain should quiet down” is a simplification that ignores how differently individual brains are wired and how many layers of inhibition interact with each other.
Who Is Most at Risk
Certain groups show up consistently in the literature as more vulnerable to paradoxical excitation. Age sits at both ends of the spectrum. Children appear especially susceptible, likely in part because the developing brain has different chloride dynamics than the adult brain. In one pediatric study, 3.4% of children who received midazolam before a procedure developed a paradoxical reaction, a rate roughly triple the commonly cited figure for adults.12PubMed. Paradoxical reaction following intravenous midazolam premedication in pediatric patients – a randomized placebo controlled trial of ketamine for rapid tranquilization Elderly patients are also at elevated risk, as documented in cases like the 80-year-old woman whose alprazolam-related symptoms tracked directly with her dose.3PubMed Central. Paradoxical Reaction to Alprazolam in an Elderly Woman with a History of Anxiety, Mood Disorders, and Hypothyroidism
Anxiety is another strong predictor. A study of paradoxical reactions during propofol-sedated endoscopy found that patients with anxiety were nearly three times as likely to have a paradoxical reaction (adjusted odds ratio of about 2.8). Four specific anxiety features had independent associations with the reaction: excess worry, sleeping problems, physical symptoms of anxiety, and health-related concerns. Younger age was also significantly associated with the reaction in that study.13PubMed. Factors related to paradoxical reactions during propofol-induced sedated endoscopy This is ironic, since anxious patients are often the ones most likely to receive sedatives in the first place.
Additional risk factors identified in endoscopy patients receiving midazolam include male sex, a history of failed sedation during a previous procedure, higher midazolam doses, and lower doses of the co-administered opioid pethidine.14PubMed. Paradoxical reaction to midazolam in patients undergoing endoscopy under sedation: Incidence, risk factors and the effect of flumazenil The dose relationship is counterintuitive at first glance: you might expect more sedative to produce more sedation, but a higher dose of a drug acting on an already-vulnerable GABA system may simply push the paradoxical pathway harder.
Genetics and Drug Metabolism
Some people’s bodies process sedatives in unusual ways that may set the stage for paradoxical excitation. The CYP450 enzyme system, which metabolizes a huge range of drugs in the liver, has well-known genetic variants. People who are “ultrarapid metabolizers” for a particular enzyme break a drug down much faster than average, and the metabolites they produce can have different effects than the parent compound.
Three documented cases of paradoxical excitation on diphenhydramine involved individuals who were ultrarapid metabolizers of CYP2D6. The researchers proposed that unusually high CYP2D6 activity converts diphenhydramine into an excitatory metabolite at an abnormally fast rate, creating stimulation instead of sedation.15PubMed. Paradoxical excitation on diphenhydramine may be associated with being a CYP2D6 ultrarapid metabolizer: three case reports Broader research has found statistical associations between CYP450 variant alleles, psychoactive medication use, and altered emotional states including aggression, supporting the idea that drug-metabolism genetics can influence whether a sedative produces its intended effect or something dramatically different.16PubMed Central. Psychoactive Medication, Violence, and Variant Alleles for Cytochrome P450 Genes
This genetic angle is still being fleshed out, and pharmacogenomic testing before routine sedation is not standard practice. But for patients who have had paradoxical reactions before, it offers a plausible biological explanation for why their brain responds differently to a drug that works perfectly well in most people.
What Happens in the Brain During Propofol-Induced Excitation
Recent EEG research has added a wrinkle to how paradoxical excitation is understood at the neural level. During propofol sedation, researchers have tracked a measure of brain signal complexity and found something surprising. In people who remained behaviorally responsive during moderate sedation (a mild form of paradoxical excitation, where the drug has not produced the expected drowsiness), one type of brain signal complexity actually went up, while a related measure went down. In people who became drowsy as expected, neither change was significant.17medRxiv. Reframing “Paradoxical” Excitation: Disentangling EEG Complexity and Entropy Reveals Resting State Dynamics Associated with Propofol Susceptibility
What makes this finding interesting is the nonlinear pattern. At light and moderate propofol doses, brain complexity increased, then dropped sharply at deep sedation when everyone eventually lost responsiveness. The researchers interpret this as evidence that paradoxical excitation is not simply a random failure of sedation but reflects a specific, measurable shift in how brain networks organize themselves under moderate drug influence. It is a pattern, not noise, though this work is still preliminary.
How Clinicians Manage It
When a patient develops paradoxical excitation from a benzodiazepine, the first-line response is usually flumazenil, a drug that directly reverses benzodiazepine effects by blocking the receptor site. Case reports consistently show that flumazenil can terminate the paradoxical reaction, sometimes within minutes.18PubMed Central. Paradoxical reaction to midazolam reversed with flumazenil This works in children as well as adults. A case involving a four-year-old girl who developed paradoxical excitation after oral midazolam was successfully reversed with flumazenil.19PubMed. Successful flumazenil reversal of paradoxical reaction to midazolam in a child
For propofol-related reactions, the situation is trickier because there is no specific reversal agent. Clinicians generally either deepen the anesthetic (pushing through the excitation phase into full unconsciousness) or wait for the drug to wear off while managing the patient’s safety. The management approach depends heavily on the clinical context. During a brief emergency department procedure, waiting a few minutes may be feasible. During a longer surgical case, switching to a different anesthetic class is often the better option.
Prevention is largely a matter of awareness and risk stratification. Patients who have had a previous paradoxical reaction should have that documented clearly in their medical record, because the reaction tends to recur with the same drug class. When anxiety is identified beforehand, some clinicians opt for alternative sedation strategies rather than benzodiazepines, though no universal protocol exists.
Animal Models and the Neuropeptide S Connection
Animal research has hinted at additional biological pathways involved in paradoxical excitation. Mice lacking the receptor for neuropeptide S, a signaling molecule involved in arousal and anxiety, turned out to be less sensitive to the sedative effects of both diazepam and alcohol compared to normal mice. In wild-type mice, neuropeptide S could weaken the sedative effects of both drugs, but this modulation was completely absent in the knockout mice.20PubMed. Paradoxical response to the sedative effects of diazepam and alcohol in C57BL/6J mice lacking the neuropeptide S receptor
This suggests that arousal pathways involving neuropeptide S interact with the sedative actions of benzodiazepines and alcohol in ways that can modulate or even override the expected sedation. If something analogous operates in humans, variations in arousal-system signaling could partly explain why some individuals are resistant to, or paradoxically excited by, drugs that sedate most people without incident. The work also points toward a broader principle: sedation is not simply a matter of one receptor system being pushed in one direction. It emerges from the balance of multiple competing systems, and when one of those systems is wired differently, the overall outcome can flip.
Why Alcohol Sometimes Produces a Similar Effect
Anyone who has watched someone become louder and more aggressive after a few drinks has seen a version of paradoxical excitation in everyday life. Alcohol, like benzodiazepines, enhances GABA signaling, and at low to moderate doses it often produces disinhibition rather than sedation. Research on the midbrain circuitry involved has shown that ethanol changes both the direct firing of neurons and the balance of inhibition and disinhibition converging on dopamine neurons, through its effects on GABAergic interneurons.21PubMed Central / American Physiological Society. The mechanism of ethanol action on midbrain dopaminergic neuron firing: a dynamic-clamp study of the role of I(h) and GABAergic synaptic integration The resulting release of dopamine contributes to the familiar pattern of early-stage alcohol euphoria and impulsivity, which is, in pharmacological terms, a paradoxical response to a depressant drug.
The difference between alcohol-related behavioral disinhibition and the clinical paradoxical excitation seen with midazolam or propofol is partly one of degree and partly one of context. With alcohol, the excitatory phase at low doses is so universal that people do not think of it as “paradoxical” at all; it is just what happens when you drink. With clinical sedatives, the expectation is much more narrowly defined: the patient should become calm and sleepy, full stop. When they do not, the deviation from the expected effect is alarming and demands immediate intervention. But the underlying neurobiology shares real common ground. Both involve GABA enhancement that, in certain circuits or at certain doses, produces net excitation through disinhibition.
The Chloride Importer as a Potential Therapeutic Target
One of the more promising leads in understanding and potentially preventing paradoxical excitation involves the chloride transporter NKCC1. This protein pumps chloride ions into neurons. When it is overactive, intracellular chloride rises, and GABA can flip from inhibitory to excitatory. The drug bumetanide, a diuretic already approved for other uses, blocks NKCC1 and can restore low intracellular chloride levels, bringing GABA signaling back to its normal inhibitory state.10SpringerOpen / Translational Medicine Communications. Is the awakening produced by benzodiazepines due to excitatory actions of GABA?
This line of research is particularly relevant in neonatal medicine and in the treatment of brain-injured patients, where GABA polarity shifts are most clearly documented. In neonatal seizures, for example, the immature brain’s naturally high chloride levels can make standard anticonvulsants that enhance GABA paradoxically ineffective or even counterproductive. Correcting the chloride imbalance with an NKCC1 blocker represents a different approach: rather than adding more GABA enhancement to a system where GABA is already excitatory, you fix the conditions that made GABA excitatory in the first place.9PubMed Central. Depolarizing GABA and developmental epilepsies Whether this strategy could be adapted to prevent paradoxical excitation during routine sedation remains to be seen, but it illustrates how deeply the phenomenon is rooted in the basic electrochemistry of nerve cells rather than in any simple notion of a drug “not working.”